Genprex Correlations
GNPX Stock | USD 0.40 0.04 11.11% |
The current 90-days correlation between Genprex and Eyenovia is 0.13 (i.e., Average diversification). The correlation of Genprex is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Genprex Correlation With Market
Significant diversification
The correlation between Genprex and DJI is 0.02 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Genprex and DJI in the same portfolio, assuming nothing else is changed.
Genprex |
Moving together with Genprex Stock
0.82 | ME | 23Andme Holding | PairCorr |
0.85 | VANI | Vivani Medical Earnings Call This Week | PairCorr |
0.62 | DNLI | Denali Therapeutics | PairCorr |
0.61 | VCYT | Veracyte | PairCorr |
0.92 | VERA | Vera Therapeutics | PairCorr |
0.75 | DSGN | Design Therapeutics Earnings Call Today | PairCorr |
0.9 | VINC | Vincerx Pharma | PairCorr |
0.95 | VKTX | Viking Therapeutics | PairCorr |
0.62 | DYAI | Dyadic International | PairCorr |
0.78 | VRDN | Viridian Therapeutics | PairCorr |
0.77 | VRPX | Virpax Pharmaceuticals | PairCorr |
0.9 | VTRS | Viatris | PairCorr |
0.92 | VTYX | Ventyx Biosciences | PairCorr |
Moving against Genprex Stock
0.9 | VALN | Valneva SE ADR Earnings Call Tomorrow | PairCorr |
0.69 | VIGL | Vigil Neuroscience | PairCorr |
0.66 | DMAC | DiaMedica Therapeutics Earnings Call Today | PairCorr |
0.63 | DVAX | Dynavax Technologies | PairCorr |
0.53 | EQ | Equillium | PairCorr |
0.41 | VERV | Verve Therapeutics | PairCorr |
0.96 | VRNA | Verona Pharma PLC Buyout Trend | PairCorr |
0.67 | EDSA | Edesa Biotech | PairCorr |
0.62 | VRTX | Vertex Pharmaceuticals | PairCorr |
0.6 | VSTM | Verastem | PairCorr |
0.56 | SRZNW | Surrozen Warrant | PairCorr |
0.5 | VTVT | vTv Therapeutics Trending | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Genprex Stock performing well and Genprex Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Genprex's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
RVPH | 5.88 | 0.24 | 0.00 | (0.04) | 0.00 | 14.56 | 67.62 | |||
GLSI | 2.21 | (0.04) | 0.00 | (0.15) | 0.00 | 4.54 | 16.98 | |||
CGTX | 4.94 | 0.47 | 0.08 | 0.20 | 4.41 | 11.84 | 39.60 | |||
GRCL | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
RVPHW | 14.23 | 0.24 | 0.00 | (0.02) | 0.00 | 28.57 | 135.71 | |||
EYEN | 6.90 | (1.83) | 0.00 | 0.97 | 0.00 | 16.56 | 65.21 | |||
RNAZ | 10.21 | (1.71) | 0.00 | (0.50) | 0.00 | 28.00 | 94.32 | |||
KOD | 5.06 | (0.71) | 0.00 | (0.47) | 0.00 | 9.24 | 45.02 | |||
EFTR | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Genprex Corporate Management
CMA CPA | Co Controller | Profile | |
Kalyn Dabbs | Sr Marketing | Profile | |
Suzanne ThorntonJones | Senior Quality | Profile | |
David Schloss | Senior Resources | Profile | |
William Gannon | Member Affairs | Profile | |
Mark MD | Chief Officer | Profile |